PrivMed® X AB

As we wrap up a challenging yet transformative 2024, we reflect on our journey towards revolutionizing personalized medication. This year, we've made significant strides in developing the world's first compact tablet press with weight-controlled dosing for personalized medication. And now we are on the last stage. While the path has been demanding, our commitment to innovation remains unwavering. We're proud of the progress we've made with our PrivMed® X AB, bringing us closer to our vision of providing 100% individually dosed tablets for every patient. As we enter 2025, we're filled with optimism and determination. We believe the coming year will bring new opportunities to refine our technology, expand our reach, and ultimately, make personalized medication a reality for patients worldwide. This holiday season, we extend our warmest wishes to our dedicated team, partners, and supporters. May your Christmas be filled with joy, and may the New Year bring renewed energy and success to all our endeavours. Here's to a future where medication is as unique as each individual. Happy Holidays and a Prosperous New Year! Warm regards The PrivMed® X AB Team #nextgenmedication #personalized #medication #pharmaceutical

We're thrilled to announce a special meeting with Ajit Singh, Chairman ACG World and our esteemed PrivMed® X AB co-investor. All his professional career he has been a visionary leader in the pharmaceutical industry, brings decades of experience and invaluable insights to our partnership. His group is Asian’s largest capsules, related machinery and packaging manufacturing enterprise and the second largest manufacturer of capsules in the world. This meeting underscores the strong belief our co-investors have in PrivMed® X AB’s revolutionary approach in personalized medication production.  We're honored to have the support of industry leader who recognize the potential of our innovative solutions. If you want to learn more about PrivMed® X AB, contact us: https://lnkd.in/ddBZQJR9 #CPHIMilan #CPHI #ACG #PrivMed #nextgenmedication #Pharmaceutical

Exciting Progress of our PrivMed® X AB Tablet Press We are thrilled to share that we are making significant strides in the development of our state-of-the-art tablet press machine with a possibility of weight-controlled dosing! As we approach the housing phase, our team is focused on ensuring that every detail meets the highest standards of quality and efficiency. Stay tuned for more updates as we continue to innovate and push the boundaries of technology. #PrivMed #innovation #nextgenmedication #pharma

And the next stage of completion at our partner NORTEC Pharma has been reached! Here you can see four pre-assembled control cabinets for PrivMed® X AB®—a unique technical challenge for René Manigk and the team, as they need to be as compact as possible. After all, PrivMed® will be the most compact tablet press in the world! 😉 Number five in the series is currently being wired, with each of the dozens of cables carefully labeled, as required by the machinery directives for CE certification. Stay tuned!

With advancements in medical research, personalized dosing has become a critical factor in effective treatment. Customizing medication dosages to fit individual patient profiles is enhancing the efficacy and safety of numerous drugs. Several medications in tablet form stand out in their effectiveness when dosed personally. For example, Warfarin, an anticoagulant, requires precise dosing based on genetic testing and regular monitoring to prevent blood clots safely. Similarly, Levothyroxine, used for thyroid hormone replacement therapy, needs to be individualized based on various patient-specific factors to achieve optimal thyroid function. Antidepressants, such as SSRIs like fluoxetine and paroxetine, often benefit from personalized dosing due to variability in metabolism and response. Genetic tests can help tailor these doses for better efficacy and fewer side effects. Antiepileptic drugs and immunosuppressants also demonstrate significantly improved outcomes with personalized dosing strategies. Personalized dosing ensures that these medications achieve their intended therapeutic effects while minimizing adverse reactions, making them much more effective when tailored to the individual patient. What other medications in tablet form do you think would benefit from personalized dosing? Share your thoughts and let's discuss

Transforming Antibiotic Treatment with a Personalized Approach The field of antibiotic treatment is undergoing a significant transformation thanks to personalized approaches. By tailoring antibiotic therapy to the unique needs of each patient, healthcare providers are achieving better outcomes and combating the growing issue of antibiotic resistance. Here’s how this approach is revolutionizing antibiotic use: Personalized approach allows for the selection of antibiotics based on an individual's genetic makeup and the specific bacterial strains involved in their infection. This precise matching ensures that the prescribed antibiotic is the most effective one for the patient, reducing the trial-and-error period often associated with traditional methods. By targeting the infection more accurately, there's less need for broad-spectrum antibiotics, which are often overused and lead to resistant bacteria. Understanding a patient's genetic profile also informs the optimal dosing of antibiotics. Pharmacogenomics studies how genes influence drug responses, enabling healthcare providers to determine the right dosage that maximizes effectiveness while minimizing side effects. This precision in dosing helps avoid under-treatment and over-treatment. Personalized approach for antibiotic treatment involves continuous monitoring to assess the infection's response, allowing quick adjustments for effective therapy. This approach includes regular assessments and the use of biomarkers to track progress. This method not only improves patient outcomes but also helps combat antibiotic resistance, representing a promising future for antibiotic therapy. #nextgenmedication #antibiotics #innovation #pharma

How a personalized approach changes outcomes in rare diseases A personalized approach is revolutionizing the treatment of rare diseases, offering new hope and better outcomes for patients. But how exactly is it making a difference? 1. Accurate Diagnosis Genetic testing is a crucial part of researching and detecting diseases. Personalized genetic testing pinpoints the exact genetic mutations responsible for rare diseases. This precision often leads to more accurate diagnoses, helping patients receive the correct treatment earlier. Understanding the genetic basis of a rare disease allows for the development of treatments tailored specifically to an individual’s genetic profile. This targeted approach is far more effective than the traditional method of finding a suitable treatment. 2. Targeted Therapies Customizing treatment plans through personalized approaches enables healthcare providers to create treatments that directly address the genetic or molecular cause of a rare disease, rather than relying on generalized treatments. Advances in gene therapy, which is inherently personalized, offer the potential to correct genetic defects at their source. This can lead to long-term solutions and even cures for certain rare diseases. Detailed information about their condition and treatment options allows patients to make informed decisions, enhancing their engagement and adherence to treatment plans. 3. Patient-Centered Care A personalized approach takes into account the patient’s lifestyle, preferences, and unique health history, leading to more holistic and effective care plans that align with the patient’s needs and circumstances.     The personalized approach to treating rare diseases is transforming patient outcomes. By focusing on the individual’s unique genetic makeup and specific disease characteristics, it offers more accurate diagnoses, effective treatments, better monitoring, and a holistic, patient-centered care experience. This shift from a one-size-fits-all model to a tailored approach provides new hope and improved quality of life for those living with rare diseases. #nextgenmedication #innovation #rarediseases

We Care About Your Health and Our Planet At PrivMed® X AB, we're dedicated to protecting both your well-being and the environment. Our commitment goes beyond just healthcare, we recognize our responsibility to foster a sustainable future. By adopting an individualized approach to patient care, we aim to: Reduce the risk of overdoses: Personalized medication tailored to each patient's unique needs. Minimize waste: Efficient use of pharmaceuticals to decrease environmental impact. Together, let's build a healthier future for ourselves and our planet. #PrivMed #nextgenmedication #pharma #innovation #environment Watch our latest video to learn: https://lnkd.in/djeRRAxM

PrivMed® X AB in Shanghai 📍 Our CEO Ingo Krause is currently in Shanghai, attending the prestigious CPHI exhibition. This event marks a fantastic opportunity for us to collaborate not only with leading Chinese API producers but also with other key players in the pharmaceutical industry. Stay with us for more updates! #PrivMed #CPHI #Shanghai #China #Api #personalized #medication #innovation #pharma

Why does it take so long to bring PrivMed® X AB onto the market? Matthias Mieves PCCA Inga Bergen Martin Winkler Precision Compounding Pharmacy Alliance for Pharmacy Compounding Kirk Donaldson Midas Pharma Sam Henson #HealthInnovations #nextgenmedication #personalizedmedication #tablets #WomensHealth #PatientsSafety